CIBC Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
29,406
+2,334
| +9% | +$84.1K | ﹤0.01% | 661 |
|
|
2025
Q1 | $843K | Buy |
27,072
+953
| +4% | +$29.7K | ﹤0.01% | 688 |
|
|
2024
Q4 | $666K | Buy |
26,119
+1,028
| +4% | +$26.2K | ﹤0.01% | 709 |
|
|
2024
Q3 | $710K | Buy |
25,091
+905
| +4% | +$25.6K | ﹤0.01% | 697 |
|
|
2024
Q2 | $638K | Buy |
24,186
+12,537
| +108% | +$331K | ﹤0.01% | 703 |
|
|
2024
Q1 | $354K | Sell |
11,649
-210
| -2% | -$6.38K | ﹤0.01% | 787 |
|
|
2023
Q4 | $333K | Buy |
+11,859
| New | +$333K | ﹤0.01% | 788 |
|
|
2023
Q1 | – | Sell |
-14,157
| Closed | -$559K | – | 1121 |
|
|
2022
Q4 | $559K | Sell |
14,157
-11,709
| -45% | -$463K | ﹤0.01% | 713 |
|
|
2022
Q3 | $1.04M | Buy |
25,866
+46
| +0.2% | +$1.85K | ﹤0.01% | 660 |
|
|
2022
Q2 | $1.09M | Sell |
25,820
-931
| -3% | -$39.1K | ﹤0.01% | 644 |
|
|
2022
Q1 | $1.04M | Buy |
26,751
+92
| +0.3% | +$3.58K | ﹤0.01% | 686 |
|
|
2021
Q4 | $1.06M | Buy |
26,659
+2,343
| +10% | +$93.3K | ﹤0.01% | 679 |
|
|
2021
Q3 | $879K | Buy |
24,316
+1,070
| +5% | +$38.7K | ﹤0.01% | 710 |
|
|
2021
Q2 | $953K | Buy |
23,246
+5
| +0% | +$205 | ﹤0.01% | 691 |
|
|
2021
Q1 | $1.01M | Buy |
+23,241
| New | +$1.01M | ﹤0.01% | 660 |
|